We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRC
2276
Commerce.com Inc Series 1
CMRC
$184M
| $2.4M | ﹤0.01% |
162,079
-19,127
| -11% | -$328K |
|
2277
GrafTech
EAF
$212M
| $2.4M | ﹤0.01% |
55,663
-109,015
| -66% | -$6.93M |
|
2278
iShares MSCI South Korea ETF
EWY
$24.1B
| $2.4M | ﹤0.01% |
50,632
+21,809
| +76% | +$1.24M |
|
|
SCU
2279
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $2.4M | ﹤0.01% |
271,167
+4,959
| +2% | +$45.9K |
|
|
TWOU
2280
DELISTED
2U Inc
TWOU
| $2.39M | ﹤0.01% |
12,765
-333
| -3% | -$86.7K |
|
2281
Standard Motor Products
SMP
$911M
| $2.38M | ﹤0.01% |
73,348
-1,673
| -2% | -$66.6K |
|
2282
TFS Financial
TFSL
$4.93B
| $2.38M | ﹤0.01% |
183,259
-6,411
| -3% | -$90.9K |
|
2283
Revolve Group
RVLV
$1.73B
| $2.38M | ﹤0.01% |
109,637
-21,468
| -16% | -$565K |
|
|
QVCGA
2284
DELISTED
QVC Group Inc Series A
QVCGA
| $2.37M | ﹤0.01% |
23,553
-421
| -2% | -$61K |
|
2285
Columbia Financial
CLBK
$1.13B
| $2.37M | ﹤0.01% |
112,038
-4,140
| -4% | -$89.4K |
|
2286
PureCycle Technologies
PCT
$1.45B
| $2.37M | ﹤0.01% |
293,140
-4,256
| -1% | -$36.4K |
|
|
RC
2287
Ready Capital
RC
$308M
| $2.37M | ﹤0.01% |
233,249
-179,742
| -44% | -$2.33M |
|
2288
BioLife Solutions
BLFS
$1.7B
| $2.36M | ﹤0.01% |
103,881
-3,859
| -4% | -$82.6K |
|
2289
Caribou Biosciences
CRBU
$164M
| $2.36M | ﹤0.01% |
223,407
-31,459
| -12% | -$293K |
|
2290
Replimune Group
REPL
$1.01B
| $2.35M | ﹤0.01% |
136,275
-7,689
| -5% | -$147K |
|
2291
Smartbird Inc
BIRD
$22.3M
| $2.34M | ﹤0.01% |
38,548
+8,689
| +29% | +$768K |
|
|
TCDA
2292
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.34M | ﹤0.01% |
223,154
+58,088
| +35% | +$635K |
|
|
HNGR
2293
DELISTED
Hanger Inc.
HNGR
| $2.33M | ﹤0.01% |
124,705
-1,894
| -1% | -$33.6K |
|
2294
iShares Core S&P 500 ETF
IVV
$902B
| $2.33M | ﹤0.01% |
6,490
-2,900
| -31% | -$1.16M |
|
|
RNAM
2295
DELISTED
Avidity Biosciences
RNAM
| $2.33M | ﹤0.01% |
142,565
-40,897
| -22% | -$782K |
|
2296
Lightwave Logic
LWLG
$1.25B
| $2.33M | ﹤0.01% |
317,018
-42,212
| -12% | -$396K |
|
2297
Consensus Cloud Solutions
CCSI
$647M
| $2.32M | ﹤0.01% |
49,135
-1,136
| -2% | -$58.5K |
|
2298
Coastal Financial
CCB
$693M
| $2.32M | ﹤0.01% |
58,360
+16,814
| +40% | +$679K |
|
|
LICY
2299
DELISTED
Li-Cycle Holdings Corp.
LICY
| $2.32M | ﹤0.01% |
54,495
-658
| -1% | -$35.8K |
|
|
RIDE
2300
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $2.32M | ﹤0.01% |
84,463
-8,304
| -9% | -$265K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.